CASP1 and diabetic kidney disease: Inhibiting oxidative stress and inflammatory reactions associated with apoptosis, significantly reduceing levels of Caspase-1, IL-1β, and NLRP3 and improving GBM thickening and inflammatory cell infiltration, thereby suppressing the development of diabetic nephropathy.